RSS-Feed abonnieren
DOI: 10.1055/s-0043-1778037
Association of Mild Iodine Insufficiency during Pregnancy with Child Neurodevelopment in Patients with Subclinical Hypothyroidism or Hypothyroxinemia
Funding The project described was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Institute of Neurological Disorders and Stroke (NINDS; HD34116, HD40512, HD27917, HD34208, HD40485, HD40560, HD53097, HD27869, HD40500, HD40545, HD27915, HD40544, HD53118, HD21410, and HD36801). Comments and views of the authors do not necessarily represent the views of the NIH.

Abstract
Objective Our objective was to evaluate whether iodine status in pregnant patients with either subclinical hypothyroidism or hypothyroxinemia in the first half of pregnancy is associated with measures of behavior and neurodevelopment in children through the age of 5 years.
Study Design This is a secondary analysis of a multicenter study consisting of two randomized, double-masked, placebo-controlled treatment trials conducted in parallel. Patients with a singleton gestation before 20 weeks' gestation underwent thyroid screening using serum thyrotropin and free thyroxine. Participants with subclinical hypothyroidism or hypothyroxinemia were randomized to levothyroxine replacement or an identical placebo. At randomization, maternal urine was collected and stored for subsequent urinary iodine excretion analysis. Urinary iodine concentrations greater than 150 μg/L were considered iodine sufficient, and concentrations of 150 μg/L or less were considered iodine insufficient. The primary outcome was a full-scale intelligence quotient (IQ) score at the age of 5 years, the general conceptual ability score from the Differential Ability Scales-II at the age of 3 if IQ was not available, or death before 3 years.
Results A total of 677 pregnant participants with subclinical hypothyroidism and 526 with hypothyroxinemia were randomized. The primary outcome was available in 1,133 (94%) of children. Overall, 684 (60%) of mothers were found to have urinary iodine concentrations >150 μg/L. Children of iodine-sufficient participants with subclinical hypothyroidism had similar primary outcome scores when compared to children of iodine-insufficient participants (95 [84–105] vs. 96 [87–109], P adj = 0.73). After adjustment, there was also no difference in IQ scores among children of participants with hypothyroxinemia at 5 to 7 years of age (94 [85 – 102] and 91 [81 – 100], Padj 1/4 0.11). Treatment with levothyroxine was not associated with neurodevelopmental or behavioral outcomes regardless of maternal iodine status (p > 0.05).
Conclusion Maternal urinary iodine concentrations ≤150 μg/L were not associated with abnormal cognitive or behavioral outcomes in offspring of participants with either subclinical hypothyroidism or hypothyroxinemia.
Key Points
-
Most pregnant patients with subclinical thyroid disease are iodine sufficient.
-
Mild maternal iodine insufficiency is not associated with lower offspring IQ at 5 years.
-
Iodine supplementation in subclinical thyroid disease is unlikely to improve IQ.
* Other members of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network are listed in Appendix A.
ClinicalTrials.gov number NCT00388297
Publikationsverlauf
Eingereicht: 12. September 2023
Angenommen: 05. Dezember 2023
Artikel online veröffentlicht:
16. Januar 2024
© 2024. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Pearce EN, Caldwell KL. Urinary iodine, thyroid function, and thyroglobulin as biomarkers of iodine status. Am J Clin Nutr 2016; 104 (Suppl. 03) 898S-901S
- 2 De Leo S, Pearce EN, Braverman LE. Iodine supplementation in women during preconception, pregnancy, and lactation: current clinical practice by U.S. obstetricians and midwives. Thyroid 2017; 27 (03) 434-439
- 3 Haddow JE, Palomaki GE, Allan WC. et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341 (08) 549-555
- 4 Pop VJ, Kuijpens JL, van Baar AL. et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol (Oxf) 1999; 50 (02) 149-155
- 5 Pop VJ, Brouwers EP, Vader HL, Vulsma T, van Baar AL, de Vijlder JJ. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin Endocrinol (Oxf) 2003; 59 (03) 282-288
- 6 Moreno-Reyes R, Glinoer D, Van Oyen H, Vandevijvere S. High prevalence of thyroid disorders in pregnant women in a mildly iodine-deficient country: a population-based study. J Clin Endocrinol Metab 2013; 98 (09) 3694-3701
- 7 Lazarus JH, Bestwick JP, Channon S. et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med 2012; 366 (06) 493-501
- 8 Casey BM, Thom EA, Peaceman AM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med 2017; 376 (09) 815-825
- 9 Hales C, Taylor PN, Channon S. et al. Controlled antenatal thyroid screening ii: effect of treating maternal suboptimal thyroid function on child cognition. J Clin Endocrinol Metab 2018; 103 (04) 1583-1591
- 10 WHO/UNICEF/ICCIDD. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination. A Guide for Programme Managers. 3rd ed. Geneva, Switzerland:: World Health Organization;; 2007
- 11 Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. Iodine status of the U.S. population, National Health and Nutrition Examination Survey, 2005–2006 and 2007–2008. Thyroid 2011; 21 (04) 419-427
- 12 Caldwell KL, Pan Y, Mortensen ME, Makhmudov A, Merrill L, Moye J. Iodine status in pregnant women in the National Children's Study and in U.S. women (15-44 years), National Health and Nutrition Examination Survey 2005-2010. Thyroid 2013; 23 (08) 927-937
- 13 Lee SY, McCarthy AM, Stohl H. et al. Urinary iodine, perchlorate, and thiocyanate concentrations in U.S. lactating women. Thyroid 2017; 27 (12) 1574-1581
- 14 Gowachirapant S, Jaiswal N, Melse-Boonstra A. et al. Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2017; 5 (11) 853-863
- 15 Taylor PN, Okosieme OE, Dayan CM, Lazarus JH. Therapy of endocrine disease: Impact of iodine supplementation in mild-to-moderate iodine deficiency: systematic review and meta-analysis. Eur J Endocrinol 2013; 170 (01) R1-R15
- 16 Levie D, Korevaar TIM, Bath SC. et al. Association of maternal iodine status with child IQ: a meta-analysis of individual-participant data. J Clin Endocrinol Metab 2019; 104 (12) 5957-5967
- 17 Ghassabian A, Steenweg-de Graaff J, Peeters RP. et al. Maternal urinary iodine concentration in pregnancy and children's cognition: results from a population-based birth cohort in an iodine-sufficient area. BMJ Open 2014; 4 (06) e005520
- 18 Abel MH, Ystrom E, Caspersen IH. et al. Maternal iodine intake and offspring attention-deficit/hyperactivity disorder: results from a large prospective cohort study. Nutrients 2017; 9 (11) E1239
- 19 Zhou SJ, Skeaff SA, Ryan P. et al. The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial. Trials 2015; 16: 563
- 20 Zhou SJ, Condo D, Ryan P. et al. Association between maternal iodine intake in pregnancy and childhood neurodevelopment at age 18 months. Am J Epidemiol 2019; 188 (02) 332-338
- 21 Monaghan AM, Mulhern MS, McSorley EM. et al. Associations between maternal urinary iodine assessment, dietary iodine intakes and neurodevelopmental outcomes in the child: a systematic review. Thyroid Res 2021; 14 (01) 14